|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01501 INT MEDICAL
Nominal 
28.000 0.000 (0.000%) | 2024/06 - Interim RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | 178,146 | 180,460 | 72,756 | 95,713 |
| Net Cash from / (used in) Investing Activities | -- | (283,812) | (316,184) | (268,084) | (221,870) |
| Net Cash from / (used in) Financing Activities | -- | 8,058 | 9,722 | (31,069) | (27,946) |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (97,608) | (126,002) | (226,397) | (154,103) |
| Cash & Cash Equivalents at beginning of period | -- | 518,266 | 640,550 | 870,132 | 1,036,783 |
| Effect of Foreign Exchange Rate Changes | -- | 3,010 | 3,718 | (3,185) | (12,548) |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 423,668 | 518,266 | 640,550 | 870,132 |
| Remarks: | Real time quote last updated: 11/11/2024 11:25 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB 100,538,000 |
| %Change | 24.889% |
| EPS / (LPS) | RMB 0.580 |
| NBV Per Share (¥) | RMB 9.538 |